Thus, our results suggest that a high co‐expression level of SLC7A11‐GPX4 was a superior predictor for poor prognosis and platinum resistance in ovarian cancer compared with the corresponding individual parameters (SLC7A11 or GPX4 expression). Here, GPX4 is linked to ovarian cancer.